*** Quick! This deal will sell out! ***
Kyle Dennis is offering 70% off his [Dollar Ace]( trading service.
Here’s your chance to trade alongside Kyle, and his smart money indicator.
Don’t miss this basement-bargain price! He might not offer it this low ever again.
[CLAIM THIS SPECIAL OFFER](
Hello trader,
You know how these insider trading cases go… one “insider” doles out information (or even trades it for themselves) and gets something in return. Of course, when I hear of “insider trading”, it really grinds my gears… and that’s why [I love to expose the thieves in the market.](There’s one interesting case surrounding Illumina Inc. (ILMN) in which one former accountant illegally tipped off a trader AHEAD of the company’s quarterly earnings release. That’s a big no-no...
Yet, we see this happen all the time.
That’s one of the reasons why I developed [Dollar Ace]( (more on that later).
[Image](
Illumina Inc. Accountant and Buddy Rake In $6.2M!
Here’s how it went down…
Martha Patricia Bustos — formerly an accountant at ILMN and a certified public accountant — was privy to non-public information. She basically knew what the company would report in its earnings announcement… and used that to her advantage.
However, Martha was “smart” enough to not trade it in her personal account. Instead, she provided her good buddy Donald Blakstad with the information. In exchange for the proprietary information, Martha received extravagant gifts and all-expense paid travel.
According to the SEC, Bustos supplied Blakstad with ILMN’s earnings announcements between April 2016 and July 2018. Blakstad using various accounts to try to hide his information… but little did he know the SEC has state-of-the-art technology that allows them to find who was behind those trades.
Blakstad realized around $4M in illicit trading profits… and the best part, he doled out that information to four other friends who made $2.2M from trading off ILMN’s non-public information.
According to the Associate Director of the SEC’s Philly Regional Office, “We used some of our latest advanced software to analyze trading data... We allege that Bustos had an obligation to keep her company’s information confidential until announced to our markets, yet she repeatedly tipped Blakstad and allowed him to take advantage of her position in return for expensive travel and luxury merchandise.”
Talk about sleazeballs.
Sure, they may be charged… but this investigation is ongoing, and who knows what will happen with these cats.
I can sit here and complain about insider trading… or I could use a proprietary options scanner [to detect their every move, and legally follow suit](. I choose the latter.
You see, a lot of the time, these [Wall Street “insiders” use the options market to cover their tracks](, and to the untrained eye, it may just look like a long-shot bet. However, I know that if someone is scooping up a bunch of options, they probably know something.
The thing is, when I follow these Wall Street whales, I know nothing about the information… all I know is the order flow and the chart pattern.
Let me show you how it all works.
Coincidence… or did they know?
Ahead of General Electric’s (GE) previous earnings announcement… [my Dollar Ace scanner detected a sizable order]( — 4,784 GE November 8th $9.50 calls went off for 19 cents, a whopping $90,896 in premium on a long-shot bet.
Of course, I don’t blindly follow these trades. I also look for a bullish chart setup.
[Image](
The stock was forming an ascending triangle — a bullish pattern… and it was trending higher, ready to break above a key resistance level.
The interesting part about this trade was the strike price of the GE calls that “insider” picked up. They purchased the $9.50 calls, right at the resistance level.
Coincidence?
I think not.
Once I did my due diligence, I figured GE could break out either before its earnings announcement or some time after… I had no idea what was going to happen, I just knew the options activity and chart setup indicated it could run higher.
I actually put GE on a watchlist and [sent it out to Dollar Ace clients](… and the next day, I alerted them when I was getting into the trade:
I bought 400 GE November 8 2019 $9.50 Calls for .14.
This is from yesterday’s watch list, after we saw some big unusual call buyers at that price yesterday. In fact, they were buying at .19 so this is even a tad cheaper. GE has earnings October 30th (before the bell) so this is definitely a riskier trade!
Take a wild guess about what happened with GE…
[Image]
Source: GE
GE smashed expectations and actually raised its cash flow outlook even with the tariffs and a projected $1.4B loss this year from Boeing’s (BA) grounding of its 737 Max.
Bingo Bango Bongo!
[Image](
GE actually broke right through that resistance level with ease…
And I locked in a whopping 200% gain overnight!
[Image](
However, I wasn’t the only one who followed this “insider” into the trade…
[Image](
[Image](
[Image](
[Image](
The thing is… [we see this happen ALL the time with my Dollar Ace strategy](… and we can directly profit from these trades.
If you want to trade alongside the Wall Street “insiders” and legally profit from their every move, then [click here to see what Dollar Ace is all about.](
Cheers to Profits!
[Image]
Kyle Dennis
[Special](
RagingBull, LLC
62 Calef Hwy. #233, Lee, NH 03861
[Click Here to stop receiving emails from kyle@biotechbreakouts.com](
[Unsubscribe from all RagingBull emails](
Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC.
If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.